Researchers use a new approach to hit an 'undruggable' target

by University of MichiganGraphical abstract. Credit:Nature Chemical Biology(2023). DOI: 10.1038/s41589-022-01248-4The protein STAT5 has long been an appealing target against cancer, b

Updated on: February 18,2024

Researchers use a new approach to hit an 'undruggable' target

by University of MichiganGraphical abstract. Credit:Nature Chemical Biology(2023). DOI: 10.1038/s41589-022-01248-4The protein STAT5 has long been an appealing target against cancer, b

Updated on:February 18,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on: January 16,2024

Financial toxicity of cancer impacts partners' quality of life, says study

by Nicole Fawcett,University of MichiganAssociations Between Health-Related Quality of Life Domains and Financial Toxicity Outcomes. Credit:JAMA Network Open(2023). DOI: 10.1001/jama

Updated on:January 16,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on: February 18,2024

Researchers identify immune cell that helps kill bladder cancer tumors

by The Mount Sinai HospitalMyeloid immune cells alongsidered blood cells in an electron micrograph of human blood. Credit: National Cancer InstituteMount Sinai researchers have made two imp

Updated on:February 18,2024

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on: April 01,2024

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

Updated on:April 01,2024

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on: May 07,2024

Palliative care in breast cancer treatment may be less likely for racial/ethnic minority patients than white patients

by American Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainDespite a steady increase in palliative care utilization from 2004 to 2020, non-Hispanic Black, Hispanic, and Asian or

Updated on:May 07,2024

Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment

by Uppsala UniversityCredit: Uppsala UniversityNearly 90 percent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to

Updated on: May 11,2024

Inhibition of ribosome biogenesis as a novel approach for multi-stage cancer treatment

by Uppsala UniversityCredit: Uppsala UniversityNearly 90 percent of all cancer patient deaths are due to metastasis. A study from Uppsala University shows that a process that allows the cells to

Updated on:May 11,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on: January 22,2024

Tumors form temporary structures to avoid immunotherapy treatments

byeLifeTumor-reactive T cells induce transient cell-in-cell structure. (A) Mean percentage of cell-in-cell tumor formations following incubation of B16F10 cells with immune cells (n=4). (B) Repr

Updated on:January 22,2024

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on: July 02,2024

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on:July 02,2024

Country-specific norms created for cancer-related quality of life

(HealthDay)—Country-specific norms have been established for the European Organisation for Research and Treatment of Cancer (EORTC) questionnaire to measure the self-reported quality of life of cancer

Updated on: April 14,2024

Country-specific norms created for cancer-related quality of life

(HealthDay)—Country-specific norms have been established for the European Organisation for Research and Treatment of Cancer (EORTC) questionnaire to measure the self-reported quality of life of cancer

Updated on:April 14,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on: March 06,2024

Advanced ovarian cancer drug gets initial 'no' for NHS in England

by Cancer Research UKCC0 Public domainA targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.In making its provisional decision on r

Updated on:March 06,2024

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on: March 30,2024

New bioinformatics tool to identify chromosomal alterations in tumor cells

by University of BarcelonaRepresentative output image generated by QATS in which two toroidal nuclei (in magenta) and four micronuclei (in green) were identified. Credit:Bioinformatics&nbsp

Updated on:March 30,2024